Cell free DNA testing-interpretation of results using an online calculator

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 1, 2015, Pages 30.e1-30.e4

  Grace, Matthew R ^a   Hardisty, Emily ^a   Green, Noah S ^a   Davidson, Emily ^a   Stuebe, Alison M ^a   Vora, Neeta L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

aneuploidy; cfDNA; screening

Indexed keywords

CELL DNA;

ANEUPLOIDY; ARTICLE; CALCULATOR; CELL FREE DNA SCREENING; CELL FREE SYSTEM; CLINICAL TRIAL (TOPIC); DIAGNOSTIC ACCURACY; DNA SCREENING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENETIC ANALYZER; GESTATIONAL AGE; HUMAN; LABORATORY DIAGNOSIS; MOLECULAR DIAGNOSIS; MOSAICISM; ONLINE SYSTEM; PREDICTIVE VALUE; PRIORITY JOURNAL; ROBERTSONIAN CHROMOSOME TRANSLOCATION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TRISOMY 21; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; FEMALE; PREGNANCY; PRENATAL DIAGNOSIS;

ANEUPLOIDY; CELL-FREE SYSTEM; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84937525457     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.05.004     Document Type: Article

References (29)

1. American College of Obstetricians and Gynecologists Screening for fetal chromosomal abnormalities. ACOG practice bulletin no. 77 Obstet Gynecol 109 2007 217 227
2. American College of Obstetricians and Gynecologists Committee on Genetics. Noninvasive prenatal testing for fetal aneuploidy. Committee opinion no. 545: Obstet Gyencol 2012;120:1532-4.
3. R.W.K. Chiu, R. Akolekar, Y.W.L. Zheng, and et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study BMJ 342 2011 c7401
4. G.E. Palomaki, E.M. Kloza, G.M. Lambert-Messerlian, and et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study Genet Med 13 2011 913 920
5. A.J. Sehnert, B. Rhees, D. Comstock, and et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood Clin Chem 57 2011 1042 1049
6. D.W. Bianchi, L.D. Platt, J.D. Goldberg, A.Z. Abuhamad, A.J. Sehnert, and R.P. Rava Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing Obstet Gynecol 119 2012 890 901
7. M.E. Norton, H. Brar, J. Weiss, and et al. Non-invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18 Am J Obstet Gynecol 207 2012 137.e1 137.e8
8. G. Ashoor, A. Syngelaki, E. Wang, and et al. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method Ultrasound Obstet Gynecol 41 2013 21 25
9. E. Pergament, H. Cuckle, B. Zimmermann, and et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort Obstet Gynecol 124 2014 210 218
10. K.H. Nicolaides, A. Syngelaki, M. Gil, V. Atanasova, and D. Markova Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y Prenat Diagn 33 2013 575 579
11. B. Zimmermann, M. Hill, G. Gemelos, and et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci Prenat Diagn 32 2012 1233 1241
12. R.P. Porreco, T.J. Garite, K. Maurel, and et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA Am J Obstet Gynecol 211 2014 365.e1 365.e12
13. M.M. Gil, M.S. Quezada, B. Bregant, M. Ferraro, and K.H. Nicolaides Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies Ultrasound Obstet Gynecol 42 2013 34 40
14. Y. Song, C. Liu, H. Qi, Y. Zhang, X. Bian, and J. Liu Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population Prenat Diagn 33 2013 700 706
15. P. Dar, K.J. Curnow, S.J. Gross, and et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing Am J Obstet Gynecol 211 2014 527.e1 527.e17
16. Daley B. Oversold prenatal tests spur some to choose abortions. The Boston Globe. Dec. 14, 2014. Available at: http://www.bostonglobe.com/metro/2014/12/14/oversold-and-unregulated-flawed-prenatal-tests-leading-abortions-healthy-fetuses/aKFAOCP5N0Kr8S1HirL7EN/story.html. Accessed Jan. 15, 2015.
17. M.T. Mennuti, A.M. Cherry, J.J.D. Morrissette, and L. Dugoff Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 209 2013 415 419
18. E.J. Verweij, M.A. de Boer, and D. Oepkes Non-invasive prenatal testing for trisomy 13: more harm than good? Ultrasound Obstet Gynecol 44 2014 112 114
19. J.R. Wax, R. Chard, A. Cartin, C. Litton, M.G. Pinette, and F.L. Lucas Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values Am J Obstet Gynecol 212 2015 548 549
20. D. Grimes, and J. Peipert Electronic fetal monitoring as a public health the arithmetic of failure Obstet Gynecol 116 2010 1397 1400
21. D.A. Grimes, and K.F. Schulz Uses and abuses of screening tests Lancet 359 2002 881 884
22. C.M. Osborne, E. Hardisty, P. Devers, and et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease Prenat Diagn 33 2013 609 611
23. R.J. Snijders, N.J. Sebire, and K.H. Nicolaides Maternal age and gestational age-specific risk for chromosomal defects Fetal Diagn Ther 10 1995 356 367
24. Materniti21 Plus. Sequenom. Available at: https://laboratories.sequenom.com/providers/materniti21-plus/. Accessed Jan. 29, 2015.
25. Harmony Prenatal Test. Ariosa Diagnostics. Available at: http://www.panoramatest.com/healthcare-provider. Accessed Jan. 29, 2015.
26. Verinata Health. Analytical Validation of the verifi® prenatal test: Enhanced Test Performance for Detecting Trisomies 21, 18, and 13 and the Option for Classification of Sex Chromosome Status. Available at: http://www.verinata.com/downloads/verifi-white-paper-Letter-Size-11-16-2012.pdf. Accessed Jan. 29, 2015.
27. Panorama Prenatal Screen. Natera, Inc. Available at: http://www.panoramatest.com/healthcare-provider. Accessed Jan. 29, 2015.
28. L.D. Platt, M.B. Janicki, T. Prosen, and et al. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States Am J Obstet Gynecol 211 2014 368.e1 368.e7
29. R.J. Wapner, J.E. Babiarz, B. Levy, and et al. Expanding the scope of noninvasive prental testing: detection of fetal microdeletion syndromes Am J Obstet Gynecol 212 2015 332.e1 332.e9